Tag Archives | antibody-drug conjugates

Biotech Stocks Strike a Bullish Tone: BLUE, IBB, REGN, SGEN…Update-1

7/28 Earnings Update Biopharmaceuticals: ALXN AMGN BMY CELG IBB is at $287. We will update our large cap valuation data after all earnings reports are in. Alexion (ALXN) missed consensus due to a change in non-GAAP reporting. GAAP EPS was $0.51. Total revenues rose 18% to $753M (Soliris was $701M)and guidance was affirmed. Amgen (AMGN) […]

Continue Reading 0

BRexit Bottom for Biotech Creates Buying Opportunity…Update-2

Update-2 …6/30 after the close Biotech stocks rallied again for the third day but momentum ebbed. Large caps were mainly in the green led by Alexion Pharmaceuticals (ALXN), Roche Holding (RHHBY) and Gilead Sciences (GILD). Mid-caps were mixed and well below recent highs. All of our core portfolio picks were up. Look to the XBI […]

Continue Reading 0

Biotech Rally Fades But Plenty of Big Movers: ASCO June 6

Biotech Rally Fades after Five Days: IBB down 0.49%, XBI down 1% Biotech stocks were weak at the onset and could not come back but the sector is still up about 7% over five days. Stocks were mixed on thursday and healthcare was weak with the XLV flat at $70.84. The big mover was Alnylam […]

Continue Reading 0

Immuno-Oncology: New Products Provide Growth and Value: ABBV BMY

Immuno-Oncology: Sweet Spot in a Biotech Bear Market We will continue to track large cap biopharma Q1 earnings looking for value+growth ideas. The financial metrics will be tracked as we did in our original post, “Large Cap Winners and Losers” on February 16 near the 2016 bottom for the sector. We put in a buy […]

Continue Reading 0

Biotech Bear Market Rally is Fading…

Biotech Bear Market Rally is Fading but Traders Are Favored Long Term Concerns on Drug Pricing Remain The biotech sector is still lagging other sectors in 2016 down 20.93% with the IBB compared to the S&P 500 (SPY) down only 2.19%. The IBB rallied over the past week in what looked like a major move up […]

Continue Reading 0

Biotech Stocks Get Traction But Still Lag Broader Market…Update-2…Rally Mode

Update-2… Broad Tradable Rally Continues 12:30 PM EST XBI leads IBB today up 4.2% vs 2.9%. XBI at $54 is now up 9.55% over 5 days and well off Feb. 11 bottom of $44. This is a broad rally today with most biotech stocks up  and the most speculative stocks are big movers. Check your holdings […]

Continue Reading 0

Biotech Stocks Lag Today’s Rally: S&P 500 Erases February Losses But Still Down 4.4% YTD…Update-1

2/23 After Close—Energy Rout Burns Biotech Stocks and NASDAQ The red screen dominated except few winners like ZIOPHARM Oncology (ZIOP) up 13.95% on a publication regarding gene editing. Another gene editing stock and recent IPO Editas Medicine (EDIT) was up 4.63% to $22.62. Large cap biopharma joined the sell-off and Fidelity Select Biotechnology Portfolio (FBIOX) […]

Continue Reading 0

Biotech Bear Market Update: Barely Bouncing Off the Bottom

Have we reached a tradeable bottom in the biotech bear market? Today’s tape showed good volume but gains faded late in session. NASDAQ up 0.35%         XLV up 0.88%-healthcare is the leading sector The biotech market bounced back early today in a broad rally then faded with the IBB up 0.625 % […]

Continue Reading 0

Biotech Stocks Snooze Through Today’s Rally Awaiting Earnings This Week: Large Cap Biopharmaceuticals… ABBV, AMGN, BIIB, BMY, CELG…Update-2

Earnings Updates-2… 1/29 Large Cap Biopharmaceuticals Valuation Models of Large Cap Biotech to be Updated Next Week IBB trying to bottom above $262 down 21.8% YTD Abbvie (ABBV) mixed Q4, maintains 2016 outlook of $4.90-$5.10;Q4 IMBRUVICA of $343M;Merck Hep-C competition coming. ABBV off 3.35%. Amgen (AMGN) beats raises 2016 forecast to $22-$22.5B, EPS $10.60-$11.00;2015 Revenues up […]

Continue Reading 0

J.P.Morgan Healthcare Conference #1: Investors Move into Life Science Stocks-Bouncing off the Bottom

J.P.Morgan Conference: Relief Rally in Life Science Stocks After Rough Start to 2016 Green screen day with improved macro and healthcare sector leading Who knew biotech stocks traded with energy? Over the next few days we will review themes and companies from presentations at the 34th Annual J.P.Morgan Healthcare Conference. Our initial focus will be […]

Continue Reading 0